You just read:

EpiVax-Novozymes Tregitope-Albumin Fusion Moves 'Paradigm-Shifting' Treatment for Diabetes Closer to Clinical Trials

News provided by

EpiVax, Inc.

Feb 12, 2013, 09:00 ET